Recent Headlines
Within Generic Drugs
SFL Selected as Finalist in the British-Swiss Business Awards
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards. - October 13, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director Invited to Speak at World Medtech Forum
Shayesteh Fürst-Ladani, Managing Director of the SFL will speak on European Day at the World Medtech Forum in Lucerne, Switzerland. - September 22, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director and Head of UK Office to Speak at DIA Combination Products Workshop in Basel, Switzerland
SFL’s team to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU. - September 08, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
SFL’s Managing Director Receives Open University Business School’s Alumni Award for Outstanding Contribution to an Organisation 2012
The Open University Business School Alumni Network nominates and elects individuals that demonstrate best the application of learnings from the Open University MBA training and achievement of outstanding results. - July 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director Invited to Chair Session and Speak at DIA 48th Annual Meeting in Philadelphia
SFL's Managing Director updates DIA attendees on Revision of European Medical Device Directives. - June 27, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM
The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.
SFL’s Senior Communication Manager to Speak at the 8th Annual Conference of the Pharmaceutical Contract Management Group
SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled “The Regulatory Framework for New Drug Innovation” at the 8th Annual Conference of the Pharmaceutical Contract Management Group. - June 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4
Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation
SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011
GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.
GenScript Launches Rush Gene Synthesis Service
Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in the global market. - December 27, 2011 - GenScript USA Inc.
GenScript Sponsors 2011 iGEM Undergraduate Synthetic Biology Competition
Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams they sponsored in 2011 iGEM undergraduate synthetic biology competition. The iGEM teams have utilized GenScript’s gene synthesis service to build novel... - December 17, 2011 - GenScript USA Inc.
SFL’s Public Affairs Now Covers Bioethics
SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Thanks Clients and Partners for Successful Collaborations
With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
FyMed Reinforces Its Drug Development Pipeline with Novel Strategies in Personalized Medicine
FyMed, Inc., a biopharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries, recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in personalized medicine. - October 06, 2011 - FyMed Inc
CannaLicense Partners with KindReviews.com to Help Medical Marijuana Patients Learn About Efficacy and Strains
CannaLicense has just announced that they have partnered with KindReviews.com to help medical marijuana patients learn about efficacy and strains. Cannalicense is a medical marijuana licensing company that works with residents of Colorado and Arizona to get a license, to treat their illnesses and... - August 19, 2011 - CannaLicense
CannaLicense Has a New Corporate Office in Denver
The medical marijuana licensing center, Cannalicense has announced the opening of their new corporate office in Denver, Colorado. The new corporate office is located at 2250 S Oneida Street, Suite 306. This change is in response to the increase in applicants since the approval for medical marijuana... - August 19, 2011 - CannaLicense
GenScript Launches Animal Model Services Worldwide
Internationally recognized biology contract research organization GenScript USA Inc. today announced that it has launched a broad spectrum of Animal Model Services for researchers to investigate the efficacy and safety profile of drug candidates. The services include in vivo drug efficacy,... - August 10, 2011 - GenScript USA Inc.
Cannalicense Recently Expanded Into Arizona and is Already Getting Patients Legal in Phoenix
Cannalicense has recently expanded their services into Arizona, and is already getting patients legal in Phoenix, for the use of medical marijuana. The service provides patients with the steps necessary toward obtaining a medical marijuana card, for the legal use of the plant, for medical... - May 26, 2011 - CannaLicense
GenScript Launches eStainTM 2.0 Protein Staining System
Internationally recognized Contract Research Organization (CRO) GenScript USA Incorporation has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System. The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved the... - May 18, 2011 - GenScript USA Inc.
GenScript Continues Deploying New Websites in Europe
GenScript USA Inc. has launched new websites at www.genscript.fr in France and at www.genscript.es in Spain to offer easier access for local French and Spanish searchers. - May 01, 2011 - GenScript USA Inc.
GenScript Will Launch Services with GANP® Technology for World Wide Market Excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. - March 25, 2011 - GenScript USA Inc.
GenScript Launches New Website in Germany
GenScript USA Inc. has launched a new website at www.genscript.de in Germany to offer easier access for local German searchers. - March 16, 2011 - GenScript USA Inc.
SynTegra Solutions Announce Expansion of Audit Services
SynTegra Solutions has announced an expansion of their services to include audits of reverse distributors. Validating return transactions to insure compliance with the manufacturer’s return policy is paramount to closing profit leaks. “With returns running at 1-2% of gross sales, many... - February 10, 2011 - SynTegra Solutions, Inc.
Local Business Teams Up with Expert Physicians to Help Michigan Families Affected by Autism
On February 12, 2011-- Michigan-based Health Dimensions Compounding Pharmacy is joining forces with five local experts on biomedical autism treatments for a one day only event that aims to educate those affected by autism on bio-medical options. - January 26, 2011 - Health Dimensions Compounding Pharmacy
GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world. To an audience of primarily research scientists from both big... - January 19, 2011 - GenScript USA Inc.
GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
GenScript received the approval of Animal Welfare Assurance for its animal facility on 9 Nov, 2010. This approval accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals. - November 24, 2010 - GenScript USA Inc.
Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials
Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening,... - November 11, 2010 - GenScript USA Inc.
PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India
PharmaZell GmbH, a European Contract Manufacturing Organization for active pharmaceutical ingredients and advanced intermediates, has once again expanded its manufacturing capabilities in India. In 2010, PharmaZell completed construction of a cGMP Kilo-lab at its R&D center in Vizag, India. - September 21, 2010 - PharmaZell
GenScript Launches CloneReadyTM Gene Collections
GenScript’s CloneReadyTM Gene Collections provide convenient and cost-effective solutions to researchers’ gene related practices. - September 09, 2010 - GenScript USA Inc.
Major Pharmaceuticals Announces Retirement and Transition Plan for Michael Redd
Major Pharmaceuticals a leading national supplier of generic over the counter pharmaceuticals today announced that Michael Redd will step down as President on August 7, 2010 for personal reasons. Redd will be succeeded by Thomas Larkin, formerly Chief Strategic Officer of The Harvard Drug Group,... - July 31, 2010 - Major Pharmaceuticals
GenScript Launches Guaranteed Gene-to-Protein Service Package Following the Technology Breakthrough from OptimumGene™ Gene Optimization
Benefiting from its patent-pending OptimumGene™ gene optimization technology breakthrough which can achieve a 10-fold or greater increase in protein expression, GenScript now offers a first-to-market guaranteed Gene-to-Protein custom service package. - April 28, 2010 - GenScript USA Inc.
Michigan Compounding Pharmacy Launches New Drug Take-Back Program for Consumer Drug Disposal
Health Dimensions Compounding Pharmacy launches new plan to take back old and unwanted medications. - April 16, 2010 - Health Dimensions Compounding Pharmacy
GenScript Recognized as Preferred Contract Supplier of Life Science Products by University of Pennsylvania
GenScript draws attention from UPENN School of Medicine for obtaining best quality products and services. - January 28, 2010 - GenScript USA Inc.
GenScript Launches Click Peptide Services
GenScript’s click peptide service aims to handle difficult peptide you intended to study. - January 21, 2010 - GenScript USA Inc.
GenScript’s Presence in Japan Relocated from Osaka to Tokyo
GenScript plans to expand its Japanese market from its capital. - January 21, 2010 - GenScript USA Inc.
XenaCare Holdings Announces Availability of Cobroxin Through the Chain Drug Marketing Association (CDMA)
XenaCare Holdings has announced that Chain Drug Marketing Association (CDMA) will begin stocking Cobroxin for distribution and sale through its 135 retail and wholesale members of regional and independent drug stores, representing over 6,000 outlets nationally. - November 10, 2009 - XenaCare Holdings
Michigan Compounding Pharmacy Makes It Easier to Fight the Flu
Local Pharmacist says it’s his job to solve his customer’s flu problems and fears this season…and he is starting by formulating Tamiflu pills into liquid to make it easier for children, the elderly, and people who just don’t like swallowing pills. - October 22, 2009 - Health Dimensions Compounding Pharmacy
GenScript Established Biology Research Collaboration with Roche
GenScript expands its drug discovery services to assay development. - September 12, 2009 - GenScript USA Inc.
GenScript Launches Antibody Sequencing Service Geared Toward Innovation
GenScript’s antibody sequencing service aims to accelerate antibody drug discovery and patent applications. - September 05, 2009 - GenScript USA Inc.
GenScript Launches 20% Off Campaign Celebrating the 5th Anniversary of Peptide Service
GenScript celebrates its 5th anniversary for its peptide services by giving customers 20% off for standard peptide synthesis and modifications. - August 23, 2009 - GenScript USA Inc.
GenScript Expands Its THE™ Elite Antibody Series
GenScript adds THE™ Anti-DYKDDDDK mAb to the THE™ antibody series. - August 18, 2009 - GenScript USA Inc.
GenScript Upgrades Plasmid Production Platform to Deliver Potent Plasmids
GenScript upgrades its plasmid production platform to enable wider scope downstream applications. - August 07, 2009 - GenScript USA Inc.
GenScript Raises $15M for Drug Discovery and Development Services Expansion —Kleiner Perkins Invests in Biology CRO Business
GenScript Inc. received $15M investment led by Kleiner Perkins Caufield & Byers (KPCB) to expand its biology and bio-reagent services in drug discovery and development. - June 26, 2009 - GenScript USA Inc.
HealthWarehouse.com, Inc. Announces Completion of Business Combination with Clacendix, Inc.
Business combination should enable HealthWarehouse.com to accelerate expansion of industry-leading $3.50 prescription drug program - May 15, 2009 - Healthwarehouse.com, Inc.
Genscript Offers Free Bio-Reagent Sample Bundles
GenScript offers high quality bundled bio-reagent samples to appreciate customers and assist in biology research under current tough economic condition. - May 10, 2009 - GenScript USA Inc.
GenScript Seeks Long-Term Collaboration Opportunities by Offering Special Partnership Promotion for Gene Synthesis
Internationally recognized biology contract research organization GenScript Corporation announces its special partnership promotion for gene synthesis service, which aims to establish a long-term, high-volume, and preferred vendor contract with its partners by offering them specially discounted... - April 22, 2009 - GenScript USA Inc.
Brookstone Pharmaceuticals Launches Generic to Zantac Syrup
Brookstone Pharmaceuticals, LLC today announced the introduction of Ranitidine Syrup, a generic equivalent to Zantac® Syrup (ranitidine hydrochloride). Ranitidine, part of the Histamine-2 blockers, is used to treat and prevent ulcers in the stomach and intestines. It can also be used to treat... - July 21, 2008 - Brookstone Pharmaceuticals, LLC
Xcelience Strengthens Development Services with Addition to Executive Team
The formulation development company’s services are led by an industry pioneer. - June 22, 2008 - Xcelience, LLC